Exelixis Inc. (EXEL)

stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Hedge Fund and Insider Trading News: George Soros, Per Johansson, Neil Woodford, Highfields Capital, Exelixis, Inc. (EXEL), J.Jill Inc (JILL), and More

Faced with Rising Far Right, Soros Foundations Look West (Reuters) BERLIN (Reuters) – George Soros’s Open Society Foundations, best known for...

Keep Reading →

June 20 - Hedge Funds, Insider Trading - Comments

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Exelixis, Symantec, Weight Watchers International and More: Here’s Why These Stocks Are Moving

Seeing as how several stocks are on the move due to earnings today, let’s take a look at some of the more notable ones, including that of Exelixis...

Keep Reading →

November 2 - News - Comments

analysing, broker, business, business people, businessmen, businesswomen, busy, data, data privacy, data protection, data security, digital security, encrypted, enterpriser, entrepreneur, file security, finance, financial, global business, global finance, homepage, information, information privacy, internet, investment, lock, online, padlock, people, privacy, professional occupation, protected, protection, secured, security, shares, stock exchange, stock market, stocks, technology, trading, web, web page, website, word, working, www CPSI Symantec

Hedge Fund and Insider Trading News: David Tepper, Tricadia Capital Management, Tiger Management, MongoDB Inc. (MDB), Infusystem Holdings Inc (INFU), Cullen/Frost Bankers, Inc. (CFR), and More

Hedge Fund Billionaire David Tepper Reaches Deal to Buy the Carolina Panthers (CNBC) Billionaire hedge fund manager David Tepper has reached a deal to...

Keep Reading →

May 16 - Hedge Funds, Insider Trading - Comments

Billionaire Fund Managers Are Bullish On These Biotech Stocks

The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy. They seem to prefer...

Keep Reading →

February 5 - Hedge Funds, News - Comments

Financial Markets Snapshot: 35 Fresh Stories Telling How is it Going in the Finance World Today

1. U.S. Stock Market: “U.S. equities traded higher on Friday as concerns about Donald Trump’s presidency recede for the time being. The Dow...

Keep Reading →

May 19 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments

The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3

Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker...

Keep Reading →

November 24 - Hedge Fund Analysis, Hedge Funds, News - Comments

trade, forex, investment, gain, stock, phone, network, view, report, money, smart, background, broker, market, laptop, table, economy, display, loss, business, urban,

Deere & Company (DE), Gas Natural Inc. (EGAS) & More: Why These Stocks are Trending Today

The US stock market is trading higher today, despite some weakness across global indexes. Among individual stocks that are showing more volatility today...

Keep Reading →

October 10 - Market Movers, News - Comments

Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More

All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first...

Keep Reading →

August 4 - Earnings Report, Market Movers, News - Comments

Facebook, CME Group Among 5 Stocks That Recently Hit 52-Week Highs

Seeing as how the S&P 500 and the Dow Jones are near record highs, it’s not surprising that many stocks have recently hit 52-week highs as well...

Keep Reading →

July 21 - Market Movers, News, Tech - Comments

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Here’s Why These Five Stocks Are Surging Today

It’s been a pretty good day on Wall Street so far as the Dow Jones Index is up almost 100 points and all three major indexes are in the green. The...

Keep Reading →

June 6 - Market Movers, News - Comments

corn, harvester, harvesting, field, ripe, monoculture, dust, agriculture, autumn, machinery, yellow, trailer, crop, combine, farm, sun, landscaped, vehicle, equipment, rural, cultivated

Pay Attention to These 5 Stocks Making Big Moves Today

The Dow Jones is slightly in the red today as market sentiment dips on a more mixed batch of earnings results being released today. Origin Agritech...

Keep Reading →

April 26 - Market Movers, News - Comments

Visa Inc (NYSE:V), Visa Electron, Card, MasterCard, Cards, Credit, bank

Why Are These Stocks Trading Deep in Red on Friday?

The key technical levels of 18,000 for the Dow and 2,100 for the S&P seem out of reach today as each index is in the red on the back of disappointing...

Keep Reading →

April 22 - Market Movers, News - Comments

Why These 5 Stocks Are Making Moves Higher Today

Wall Street has recorded moderate gains on the first day of March, with crude prices being the main catalyst for the stock exchanges. Meanwhile, there...

Keep Reading →

March 1 - Market Movers, News - Comments

Did Hedge Funds Sell Out Of Exelixis, Inc. (EXEL) Too Soon? Shares Jump On Regulatory Approval of Cobimetinib

The shares of Exelixis, Inc. (NASDAQ:EXEL) have jumped by 3.01% in today’s trading session, as the company announced the first regulatory approval...

Keep Reading →

August 27 - Hedge Funds, News - Comments

Exelixis, Inc. (EXEL) Soars Following Cancer Drug Trial Data, But Competition Looms

Shares of Exelixis, Inc. (NASDAQ:EXEL) have soared by more than 50% today following the release of positive phase 3 trial data from a test of its cancer...

Keep Reading →

July 20 - Hedge Funds, Market Movers, News - Comments

An Excellent Investment in the Biotech Space?

According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected...

Keep Reading →

September 23 - News - Comments

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc...

Keep Reading →

September 17 - News - Comments

New York Community Bancorp, Inc. (NYSE:NYCB)

New York Community Bancorp, Inc. (NYCB), Exelixis, Inc. (EXEL): Here’s What This $53 Billion Hedge Fund Company Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...

Keep Reading →

September 10 - News - Comments

Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)

If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than...

Keep Reading →

September 4 - News - Comments

Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)

What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can...

Keep Reading →

September 3 - News - Comments

Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?

Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use...

Keep Reading →

August 30 - News - Comments

NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and...

Keep Reading →

August 28 - News - Comments

Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies

In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc. (NASDAQ:EXEL), Vertex Pharmaceuticals...

Keep Reading →

August 23 - News - Comments

Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential

Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S. has a number of small cap stocks...

Keep Reading →

July 17 - News - Comments

Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)

Is Puma Biotechnology Inc (NYSE:PBYI) a buy here? Hedge funds are betting on the stock. The number of bullish hedge fund bets improved by 2 lately. In...

Keep Reading →

June 10 - News - Comments

Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) investors should pay attention to an increase in hedge fund interest in recent months. To most stock holders...

Keep Reading →

June 3 - News - Comments

Bristol Myers Squibb Co. (BMY), Ariad Pharmaceuticals, Inc. (ARIA): ASCO Investment Ideas

The American Society of Clinical Oncology annual meeting kicks off today. The scientific conference is the premier place for oncology companies to present...

Keep Reading →

June 3 - News - Comments

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)

ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas

Over the past three months, we’ve taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S. this year according to the...

Keep Reading →

June 3 - News - Comments

Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...

Keep Reading →

May 31 - Hedge Funds - Comments

Chesapeake Energy Corporation (CHK), Discovery Communications Inc. (DISCA): Here’s What This $21 Billion Hedge Fund Company Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...

Keep Reading →

May 28 - Hedge Funds - Comments

SolarCity Corp (SCTY), Exelixis, Inc. (EXEL): Watch These Stocks

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on...

Keep Reading →

May 8 - News - Comments

AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players

As I noted eight weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...

Keep Reading →

April 29 - News - Comments

Amazon.com, Inc. (AMZN), And How The Roth IRA Rules!

If you’re going through life assuming that there isn’t much difference between a traditional IRA and a Roth IRA, you’re doing yourself...

Keep Reading →

April 24 - News - Comments

Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has seen a decrease in enthusiasm from smart money in recent months. According to most investors, hedge funds...

Keep Reading →

April 8 - News - Comments

Amarin Corporation plc (ADR) (AMRN), Exelixis, Inc. (EXEL): Here’s What This 220% Gainer Has Been Buying and Selling

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...

Keep Reading →

March 20 - Hedge Funds - Comments

Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) – Tackling Cancer: Prostate Cancer’s Biggest Current and Upcoming Players

As I commented last week, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...

Keep Reading →

March 5 - News - Comments

Celgene Corporation (CELG)’s New Acquisition — of Celgene

Celgene Corporation (NASDAQ:CELG) announced on Wednesday a $600 million deal to buy a stake in a growing biotech with several successful products on the...

Keep Reading →

February 20 - News - Comments

Dynavax Technologies Corporation (NASDAQ:DVAX)

5 Can’t-Miss Health-Care Events This Week: Dynavax Technologies Corporation (DVAX) and More

Earnings are once again going to steal the spotlight this week, with four of the five can’t-miss stories in the health-care sector revolving around...

Keep Reading →

February 18 - News - Comments

5 Reasons to Worry About Next Week: Exelixis, Inc. (EXEL) and More

The economy is showing signs of fumbling the recovery. Despite the rosy State of the Union address on Tuesday, consumers are still coping with the ramifications...

Keep Reading →

February 15 - News - Comments

5 Can’t-Miss Health-Care Events This Week: Exelixis, Inc. (EXEL), Regeneron Pharmaceuticals Inc (REGN)

With no major health-care conferences on the docket this week, and the Food and Drug Administration ruling two days early on Celgene Corporation (NASDAQ...

Keep Reading →

February 11 - News - Comments

Biotech: Core and Explore – Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)

Giant pharmaceutical companies are looking for the next big drug, and so are much smaller biotech outfits. Because of the methods they use, biotechs are...

Keep Reading →

January 22 - News - Comments

Posts Tagged ‘Exelixis Inc. (EXEL)’